Explaining differences in stakeholder take up of disease management programmes: A comparative analysis of policy implementation in Austria and Germany

Health Policy
Laura SchangThomas Czypionka

Abstract

Understanding why policies to improve care for people with chronic conditions fail to be implemented is a pressing issue in health system reform. We explore reasons for the relatively high uptake of disease management programmes (DMPs) in Germany, in contrast to low uptake in Austria. We focus on the motivation, information and power of key stakeholder groups (payers, physician associations, individual physicians and patients). We conducted a comparative stakeholder analysis using qualitative data from interviews (n=15 in Austria and n=26 in Germany), legal documents and media reports. Stakeholders in Germany appeared to have systematically stronger motivation, exposure to more positive information about DMPs and better ability to implement DMPs than their counterparts in Austria. Policy in Austria focused on financial incentives to physicians only. In Germany, limited evidence about the quality improvement and cost savings potential of DMPs was mitigated by strong financial incentives to sickness funds but proved a fundamental obstacle in Austria. Efforts to promote DMPs should seek to ensure the cooperation of payers and patients, not just physicians, using a mix of financial and non-financial instruments suited to the contex...Continue Reading

References

Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Mar 17, 2000·IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society·E R CarsonA V Roudsari
Jul 13, 2000·Archives of Pediatrics & Adolescent Medicine·M D CabanaC S Rand
Sep 30, 2000·Health Policy and Planning·Z Varvasovszky, R Brugha
Apr 4, 2003·Health Affairs·Sheila LeathermanMaureen Bisognano
Jun 3, 2004·JAMA : the Journal of the American Medical Association·Derek YachKaren J Hofman
Sep 30, 2004·Journal of Public Health·Christian A Gericke, Reinhard Busse
Apr 16, 2005·Evidence-based Nursing·Paul Glasziou, Brian Haynes
Oct 6, 2005·Qualitative Health Research·Hsiu-Fang Hsieh, Sarah E Shannon
Apr 26, 2008·BMJ : British Medical Journal·Helena Legido-QuigleyNiek Klazinga
Aug 12, 2009·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN National Institute of Neurological Disorders, National Institutes of Health
Sep 8, 2009·Health Economics, Policy, and Law·Chris Ham
Sep 3, 2010·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors· National Association Of Ems Physicians
Sep 3, 2010·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors· National Association Of Ems Physicians And National Association Of State Ems Officials
May 27, 2011·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·UNKNOWN National Association Of EMS Physicians
Jul 30, 2011·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·UNKNOWN National Association of EMS Physicians
Jan 10, 2012·Health Economics, Policy, and Law·Ellen NolteHubertus J M Vrijhoef
Jan 2, 2013·Health Policy·Florian BuchnerJuergen Wasem

❮ Previous
Next ❯

Citations

Apr 25, 2020·Health Economics, Policy, and Law·Ina TapagerKarsten Vrangbæk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lege artis medicinae : új magyar orvosi hírmondó
Eva Belicza, Tamás Evetovits
Quality & Safety in Health Care
A RashidianI Russell
Health Policy
Apostolos TsiachristasMaureen Pmh Rutten-Van Mölken
Journal of Health Services Research & Policy
Marisa RattoSimon Burgess
© 2022 Meta ULC. All rights reserved